Understanding molecular mechanisms in peritoneal dissemination of colorectal cancer

Unresponsiveness of colon cancer to BRAF(V600E) inhibition through feedback activation of EGFR

(2012) Anirudh Prahallad et al.   NATURE

Population-based survival of patients with peritoneal carcinomatosis from colorectal origin in the era of increasing use of palliative chemotherapy

(2011) Y. L. B. Klaver et al.   ANNALS OF ONCOLOGY

Hallmarks of Cancer: The Next Generation

(2011) Douglas Hanahan et al.   CELL

Intraoperative tumor-specific fluorescence imaging in ovarian cancer by folate receptor-α targeting: first in-human results

(2011) Gooitzen M van Dam et al.   NATURE MEDICINE

Live Free or Die

(2010) Craig Horbinski et al.   AMERICAN JOURNAL OF PATHOLOGY

Changes induced by surgical and clinical factors in the pharmacology of intraperitoneal mitomycin C in 145 patients with peritoneal carcinomatosis

(2010) Kurt Van der Speeten et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

Kallikrein-Related Peptidase 7 Promotes Multicellular Aggregation via the α5β1Integrin Pathway and Paclitaxel Chemoresistance in Serous Epithelial Ovarian Carcinoma

(2010) Ying Dong et al.   CANCER RESEARCH

Clinicopathologic Significance of HIF-1α, CXCR4, and VEGF Expression in Colon Cancer

(2010) Yugang Wu et al.   Clinical & Developmental Immunology

Curative treatment of colorectal peritoneal carcinomatosis: Current status and future trends

(2010) L. Maggiori et al.   EJSO

Prognostic factors and oncologic outcome in 146 patients with colorectal peritoneal carcinomatosis treated with cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy: Italian multicenter study S.I.T.I.L.O.

(2010) F. Cavaliere et al.   EJSO

Overexpression of Epithelial Cell Adhesion Molecule in Primary, Metastatic, and Recurrent/Chemotherapy-Resistant Epithelial Ovarian Cancer

(2010) Stefania Bellone et al.   INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER

CD95 is a key mediator of invasion and accelerated outgrowth of mouse colorectal liver metastases following radiofrequency ablation

(2010) Maarten W. Nijkamp et al.   JOURNAL OF HEPATOLOGY

Reversal of TNP-470-Induced Endothelial Cell Growth Arrest by Guanine and Guanine Nucleosides

(2010) J. Hines et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

Anti-β1 Integrin Antibody Reduces Surgery-Induced Adhesion of Colon Carcinoma Cells to Traumatized Peritoneal Surfaces

(2009) Steven J. Oosterling et al.   ANNALS OF SURGERY

Accelerated Perinecrotic Outgrowth of Colorectal Liver Metastases Following Radiofrequency Ablation is a Hypoxia-Driven Phenomenon

(2009) Maarten W. Nijkamp et al.   ANNALS OF SURGERY

The Perioperative Period is an Underutilized Window of Therapeutic Opportunity in Patients With Colorectal Cancer

(2009) Gerben J. van der Bij et al.   ANNALS OF SURGERY

A Systematic Review and Meta-Analysis of Cytoreductive Surgery with Perioperative Intraperitoneal Chemotherapy for Peritoneal Carcinomatosis of Colorectal Origin

(2009) Christopher Cao et al.   ANNALS OF SURGICAL ONCOLOGY

Primary human colonic epithelial cells are transiently protected from anoikis by a Src-dependent mechanism

(2009) Claudia Hofmann et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

The use of kallikrein-related peptidases as adjuvant prognostic markers in colorectal cancer

(2009) M Talieri et al.   BRITISH JOURNAL OF CANCER

EMT, the cytoskeleton, and cancer cell invasion

(2009) Mahmut Yilmaz et al.   CANCER AND METASTASIS REVIEWS

Safety, tolerability, and pharmacokinetics of the anti-IGF-1R monoclonal antibody figitumumab in patients with refractory adrenocortical carcinoma

(2009) Paul Haluska et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

The role of cell adhesion molecules in the progression of colorectal cancer and the development of liver metastasis

(2009) Konstantinos A. Paschos et al.   CELLULAR SIGNALLING

Omental immune aggregates and tumor metastasis within the peritoneal cavity

(2009) Elizabeth W. Sorensen et al.   IMMUNOLOGIC RESEARCH

Safety, pharmacokinetics, and preliminary activity of the anti-IGF-1R antibody figitumumab (CP-751,871) in patients with sarcoma and Ewing's sarcoma: a phase 1 expansion cohort study

(2009) David Olmos et al.   LANCET ONCOLOGY

PRL-3 promotes the motility, invasion, and metastasis of LoVo colon cancer cells through PRL-3-integrin β1-ERK1/2 and-MMP2 signaling

(2009) Lirong Peng et al.   Molecular Cancer

Src kinases as therapeutic targets for cancer

(2009) Lori C. Kim et al.   Nature Reviews Clinical Oncology

Clinical significance of kallikrein-related peptidase 7 (KLK7) in colorectal cancer

(2009) Maroulio Talieri et al.   THROMBOSIS AND HAEMOSTASIS

Anoikis: A necessary death program for anchorage-dependent cells

(2008) Paola Chiarugi et al.   BIOCHEMICAL PHARMACOLOGY

Wilms tumor gene protein 1 is associated with ovarian cancer metastasis and modulates cell invasion

(2008) Maria V. Barbolina et al.   CANCER

The Met tyrosine kinase receptor in development and cancer

(2008) Alessandra Gentile et al.   CANCER AND METASTASIS REVIEWS

Loss of E-Cadherin Promotes Ovarian Cancer Metastasis via  5-Integrin, which Is a Therapeutic Target

(2008) K. Sawada et al.   CANCER RESEARCH

Matrix Metalloproteinase 9 Is a Mediator of Epidermal Growth Factor-Dependent E-Cadherin Loss in Ovarian Carcinoma Cells

(2008) K. D. Cowden Dahl et al.   CANCER RESEARCH

Plasma Insulin-like Growth Factors, Insulin-like Binding Protein-3, and Outcome in Metastatic Colorectal Cancer: Results from Intergroup Trial N9741

(2008) C. S. Fuchs et al.   CLINICAL CANCER RESEARCH

Met-driven invasive growth involves transcriptional regulation of Arhgap12

(2008) A Gentile et al.   ONCOGENE

Presence of HIF-1 and related genes in normal mucosa, adenomas and carcinomas of the colorectum

(2008) Astrid E. Greijer et al.   VIRCHOWS ARCHIV